David Chao. Dave Chao is a founder and the principal owner of Nectagen. He is also President and CEO of the Stowers Institute for Medical Research and BioMed Valley Discoveries, Inc. Dave's involvement in Nectagen is a private activity and unrelated to his roles at the Stowers Institute or BioMed Valley. Previously Dave worked at the Novartis Institute for Biomedical Research, two small biotech start-ups and McKinsey & Co. He is a member of the boards of the Stowers Institute, BioMed Valley Discoveries, the American Century Companies, and the Pembroke Hill School. Dave holds a Ph.D. in Biology from the Massachusetts Institute of Technology, where he was a pre-doctoral fellow of the Howard Hughes Medical Institute. He also received a combined M.A. and B.A. in Biology from Harvard University. Dave co-invented Nectagen's nanoCLAMP technology and designed its database infrastructure.
Richard Suderman. Rich Suderman is a founder and Director of Research of Nectagen. Rich holds a Ph.D. in Biochemistry, a B.S. degree in Chemical Engineering, and a B.S. degree in Biochemistry from Kansas State University. Previously, Rich held a post-doctoral appointment at the University of Georgia. Rich co-invented the nanoCLAMP technology, serves as principal investigator for Nectagen's research grants, and leads all technology development, operations and manufacturing at the company.